MYANANDI THAN: Open Payments
NPI 1356426522 · JUNEAU, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 12 payments from 6 companies in 2025. Trend: 2023 $159 · 2024 $650 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $110 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| GENZYME CORPORATION | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: NUCALA, ELIQUIS, AIRSUPRA, AREXVY, DUPIXENT, FARXIGA, SHINGRIX, LEQVIO.
Industry payments across AK — which companies pay providers there.
